ArticleCureus2026
A Rare Case of Pulmonary Artery Intimal Sarcoma Diagnosed Antemortem by Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary pulmonary artery sarcoma (PPAS) is a rare malignancy often misdiagnosed as pulmonary thromboembolism. Antemortem diagnosis is often difficult because of the tumor's deep intravascular location and challenges in obtaining tissue samples. We report a 72-year-old man with pulmonary artery intimal sarcoma diagnosed antemortem using endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). Contrast-enhanced computed tomography demonstrated a heterogeneously enhancing intraluminal pulmonary artery lesion, and positron emission tomography/computed tomography revealed intense fluorodeoxyglucose uptake (SUVmax 18.4). Histopathological examination showed atypical spindle-shaped cells positive for vimentin and focally positive for α-smooth muscle actin, consistent with intimal sarcoma. The patient received radiation therapy and doxorubicin-based chemotherapy but died 25 weeks after admission. Consistent with previous reports, this case illustrates the aggressive clinical course and diagnostic challenges of PPAS. It also highlights the importance of considering PPAS in patients with atypical pulmonary embolism and demonstrates the utility of EUS-FNA as a minimally invasive approach for obtaining a definitive diagnosis of centrally located pulmonary artery tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.